8 Followers HKEX:2348 - Dawnrays Pharmaceutical (Holdings) Ltd

Dawnrays Pharmaceutical Holdin
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend ¹
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2008 Q2	2008 Q4	2009 Q2	2009 Q4	2010 Q2	2010 Q4	2011 Q2	2011 Q4	2012 Q2	2012 Q4	2013 Q2	2013 Q4	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q2	2016 Q4	2017 Q2	2017 Q4	2018 Q2	2018 Q4	2019 Q2	2019 Q4	2020 Q2	2020 Q4	2021 Q2	2021 Q4	2022 Q2	2022 Q4	2023 Q2	2023 Q4	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	607.82M 13.6%	556.57M -8.4%	623.48M 12.0%	654.2M 4.9%	649.92M -0.7%	501.23M -22.9%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	235.2M -5.7%	248.39M 5.6%	231.2M -6.9%	272.93M 18.0%	288.07M 5.5%	221.56M -23.1%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	372.62M 30.3%	308.17M -17.3%	392.28M 27.3%	381.27M -2.8%	361.85M -5.1%	279.67M -22.7%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	384.76M 8.8%	382.96M -0.5%	383.19M 0.1%	450.21M 17.5%	301.13M -33.1%	418.63M 39.0%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	149.56M 43.5%	134.57M -10.0%	151.99M 12.9%	177.28M 16.6%	13.06M -92.6%	197.07M 1408.8%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	223.06M 22.8%	173.6M -22.2%	240.29M 38.4%	203.99M -15.1%	348.79M 71.0%	82.6M -76.3%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	210.82M 24.5%	228.24M 8.3%	225.59M -1.2%	212.82M -5.7%	327.21M 53.8%	86.85M -73.5%
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	166.44M 20.2%	191.53M 15.1%	171.66M -10.4%	186.4M 8.6%	255.94M 37.3%	70.06M -72.6%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.111 23.5%	0.128 15.1%	0.115 -10.5%	0.124 8.5%	0.171 37.3%	0.047 -72.6%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.111 23.2%	0.127 14.4%	0.114 -9.8%	0.124 8.5%	0.17 37.2%	0.047 -72.6%